Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy. [electronic resource]
Producer: 20030130Description: 144-8 p. digitalISSN:- 0022-1899
- Acquired Immunodeficiency Syndrome -- drug therapy
- Adult
- Anti-HIV Agents -- therapeutic use
- CD4 Lymphocyte Count
- DNA, Viral -- analysis
- Didanosine -- administration & dosage
- Disease Progression
- HIV-1 -- genetics
- Humans
- Multivariate Analysis
- Prognosis
- RNA, Viral -- blood
- Zalcitabine -- administration & dosage
- Zidovudine -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.